3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Lung Neoplasms
2
Vipoma
1
Somatostatinoma
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Neuroendocrine Tumors
1
Neoplasms
1
Insulinoma
1
Glucagonoma
1
Gastrinoma
1
Fallopian Tube Neoplasms
1
Esophageal Neoplasms
1
Carcinoma, Ovarian Epithelial
1
Carcinoma, Non-Small-Cell Lung
1
Carcinoma, Islet Cell
1
Adenoma, Islet Cell
1
Interventions
Magnetic Resonance Spectroscopy
5
lenvatinib
3
cabozantinib
3
Sunitinib
3
Iodine-131
3
trametinib
2
Fluorodeoxyglucose F18
2
2-phenyl-6-(2'-(4'-(ethoxycarbonyl)thiazolyl))thiazolo(3,2-b)(1,2,4)triazole
2
vandetanib
1
tremelimumab
1
tanespimycin
1
romidepsin
1
pembrolizumab
1
omipalisib
1
durvalumab
1
dabrafenib
1
cediranib
1
aflibercept
1
Vorinostat
1
Thyrotropin Alfa
1
Specimen Handling
1
Sorafenib
1
Pharmacogenomic Testing
1
Nivolumab
1
Lenalidomide
1
Ipilimumab
1
Iodine-124
1
Gefitinib
1
Decitabine
1
CTLA-4 Antigen
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Adenocarcinoma, Follicular
×
motesanib diphosphate
×
Clear all
No trials found.